Alexandra N. Riemenschneider

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

Jonathon Torchia, Brian Golbourn, Shengrui Feng et al. · Cancer Cell · 2016 · 254 citations · Full text

Medicine, Genetics, Oncology +12

Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound

Daniel Coluccia, Carlyn A. Figueiredo, Megan Wu et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 134 citations

Pharmacy, Oncology, Pharmaceutics +17

A role for activated Cdc42 in glioblastoma multiforme invasion

Hidehiro Okura, Brian Golbourn, Uswa Shahzad et al. · Oncotarget · 2016 · 46 citations · Full text

Medicine, Neurosurgery, Oncology +14

Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition

Brittany Campbell, Melissa A. Galati, Simone C. Stone et al. · Cancer Discovery · 2021 · 39 citations · Full text

Medicine, Genetics, Oncology +17

<i>CASCADES</i>, a novel <i>SOX2</i> super‐enhancer‐associated long noncoding <scp>RNA</scp>, regulates cancer stem cell specification and differentiation in glioblastoma

Uswa Shahzad, Marina Nikolopoulos, Christopher Li et al. · Molecular Oncology · 2024 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +17